The BCMA-Targeted Fourth-Generation CAR-T Cells Secreting IL-7 and CCL19 for Therapy of Refractory/Recurrent Multiple Myeloma

Overview of attention for article published in Frontiers in immunology, March 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 45,682 followers.

RT @CARTTherapy: The #BCMA-Targeted Fourth-Generation #CAR-T Cells Secreting IL-7 and CCL19 for Therapy of Refractory/Recurrent Multiple #M…

RT @CARTTherapy: The #BCMA-Targeted Fourth-Generation #CAR-T Cells Secreting IL-7 and CCL19 for Therapy of Refractory/Recurrent Multiple #M…

RT @CARTTherapy: The #BCMA-Targeted Fourth-Generation #CAR-T Cells Secreting IL-7 and CCL19 for Therapy of Refractory/Recurrent Multiple #M…

RT @CARTTherapy: The #BCMA-Targeted Fourth-Generation #CAR-T Cells Secreting IL-7 and CCL19 for Therapy of Refractory/Recurrent Multiple #M…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.